Sign in
4

Changes in Ownership

Grace Therapeutics, Inc. Filed Acc 0001062993-23-014994

Options or other derivatives

  • Chief Executive Officer acquired 208,334 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Kohli Prashant Chief Executive Officer 2023-07-14 Grant or award · Stock Options (Right to Buy) +208,334 208,334 D
Loading xslF345X05/form4.xml…